HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Dietary Supplement Market US FDA Is Regulating Isn’t Your 1994 DSHEA Version

Executive Summary

“In the last 30 years, we've seen this sort of explosion, and it's not just more products and more sales. We're talking about more complex products,” says Cara Welch, FDA Office of Dietary Supplement Programs director. “Today's products are not the products from 1994.”

You may also be interested in...

‘Lack Of Understanding’ Here, Spiked Product There Add Up To US Supplement Industry Image Problem

Research suggesting FDA more stringently regulate claims for fish oil supplements impresses industry as another sign the agency’s regulation and the requirements fulfilled by compliant businesses aren’t appreciated or understood. FDA announcement of ED drugs in products labeled as supplements shows agency must be aware students are starting or returning to classes.

US FDA’s Human Foods Program Reorganization Plan Isn’t Palatable To Supplement Industry

Reorganization of CFSAN and related ORA operations into “unified Human Foods Program” would move ODSP into Office of Food Chemical Safety, Dietary Supplements and Innovation. Stakeholders plan to influence agency against making the change, or sway lawmakers to object, similar to what they did pushing for ODSP’s establishment less than 10 years ago.

Absent Mandatory Listing, US FDA Acknowledges Its Supplement Directory Isn’t Comprehensive

Two weeks after Commissioner Califf notes he supports mandatory listing of supplements and two months after previous session of Congress ended without imposing requirement, agency is doing what it can to publish information about ingredients in supplements sold in the country.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts